PrEP During COVID-19: 5 Things to Know PrEP During COVID-19: 5 Things to Know
Accessing care at the places where PrEP is prescribed is harder to do during a pandemic. Here are five things to know about PrEP in the era of COVID-19.CDC Expert Commentary
[MSF] Geneva -- In a landmark move, India and South Africa on 2 October asked the World Trade Organization (WTO) to allow all countries to choose to neither grant nor enforce patents and other intellectual property (IP) related to COVID-19 drugs, vaccines, diagnostics and other technologies for the duration of the pandemic, until global herd immunity is achieved. This bold step is akin to efforts by governments nearly 20 years ago, which spearheaded the use of affordable generic HIV/AIDS medicines, and, if approved, could
Purpose of review The Coronavirus Disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global health threat associated with major socioeconomic disruptions. Understanding on the transmission characteristics of SARS-CoV-2 is crucial for optimizing preventive strategies. Recent findings SARS-CoV-2 can be transmitted efficiently between persons through respiratory droplets and direct and indirect contact. The significance of airborne droplet nuclei in SARS-CoV-2 transmission in the community setting is less clear. SARS-CoV-2 RNA and live viral particles ma...
Purpose of review Coronavirus disease 2019 (COVID-19) is a highly contagious and potentially lethal pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). No specific antiviral treatment is currently available. The purpose of this review is to highlight the main repurposed drug treatments with in-vitro or in-vivo efficacy against the SARS-CoV-2. Recent findings Recent clinical trials suggested remdesivir, IFN-β-1b and favipiravir have potential clinical and/or virological benefits on patients with COVID-19. Short course of stress dose of corticosteroids might be used as adjunctive tr...
This article share the experience unprecedented from Shenzhen. We have to adapt our care and service to continue to engage PLWH to avoid poor outcomes. More research is needed to know the long-term implications of pandemic for the health of PLWH.
A critical difference between AIDS and the current pandemic is that Covid-19 can be controlled by public health means.
During the COVID-19 pandemic, hospitals faced increasing pressure, where people living with HIV risked to either acquire SARS-CoV-2 and to interrupt the HIV continuum of care.
CONCLUSIONS: Protecting pregnant and breastfeeding women, infants, children and adolescents from acquiring SARS-CoV-2 while sustaining essential HIV services is an immense global health challenge. Tailored, family friendly programme adaptations for case-finding, ART delivery and viral load monitoring for these populations have the potential to limit SARS-CoV-2 transmission while ensuring the continuity of life-saving HIV case identification and treatment efforts. PMID: 32996705 [PubMed - in process]
[Daily Maverick] During the HIV pandemic, doctors were traumatised by the government's indifference towards patients' lack of access to treatment. In the case of Covid-19, some physicians say, they have to cope with the devastating consequences of most of the country's health resources having been allocated to one disease.
[Nation] More young Kenyans could end up being infected with HIV due to the prolonged closure of schools over Covid-19 pandemic fears.
[UNFPA] Olupandu, Namibia -- While the world is battling the COVID-19 pandemic, Secilia Jacob*, 18, is fighting her own battle with a different virus. She is learning to come to terms with her HIV status.